Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year book value per share growth
Latest
55.15%
↑ 1053% vs avg
Percentile
P95
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
4.78%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 55.15% |
| Q3 2025 | -2.79% |
| Q2 2025 | -17.55% |
| Q1 2025 | -1.45% |
| Q4 2024 | -11.69% |
| Q3 2024 | -16.54% |
| Q2 2024 | 42.06% |
| Q1 2024 | 296.69% |
| Q4 2023 | -40.23% |
| Q3 2023 | -28.04% |
| Q2 2023 | -19.51% |
| Q1 2023 | -10.70% |
| Q4 2022 | -0.25% |
| Q3 2022 | -13.19% |
| Q2 2022 | -14.81% |
| Q1 2022 | -8.72% |
| Q4 2021 | -11.47% |
| Q3 2021 | -8.69% |
| Q2 2021 | -8.59% |
| Q1 2021 | 27.23% |
| Q4 2020 | -6.78% |
| Q3 2020 | 156.17% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | -4.42% |
| Q3 2017 | -6.31% |
| Q2 2017 | -12.49% |
| Q1 2017 | -5.40% |
| Q4 2016 | -9.79% |
| Q3 2016 | -16.10% |
| Q2 2016 | -15.16% |
| Q1 2016 | 5.50% |
| Q4 2015 | -7.47% |
| Q3 2015 | -4.21% |
| Q2 2015 | 17.14% |
| Q1 2015 | -6.19% |